Spero Therapeutics, Inc. (SPRO)
1.20
-0.02
(-1.64%)
USD |
NASDAQ |
Sep 01, 15:48
Spero Therapeutics Total Long Term Debt (Quarterly) : 0.043M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.043M |
| March 31, 2026 | 0.507M |
| December 31, 2025 | 0.939M |
| September 30, 2025 | 1.452M |
| June 30, 2025 | 1.771M |
| March 31, 2025 | 2.165M |
| December 31, 2024 | 2.551M |
| September 30, 2024 | 2.883M |
| June 30, 2024 | 3.206M |
| March 31, 2024 | 3.519M |
| December 31, 2023 | 3.825M |
| September 30, 2023 | 4.12M |
| June 30, 2023 | 4.407M |
| March 31, 2023 | 4.685M |
| December 31, 2022 | 4.957M |
| September 30, 2022 | 5.218M |
| June 30, 2022 | 5.473M |
| March 31, 2022 | 56.63M |
| Date | Value |
|---|---|
| December 31, 2021 | 54.39M |
| September 30, 2021 | 6.191M |
| June 30, 2021 | 6.43M |
| March 31, 2021 | 6.663M |
| December 31, 2020 | 6.891M |
| September 30, 2020 | 6.503M |
| June 30, 2020 | 4.623M |
| March 31, 2020 | 4.521M |
| December 31, 2019 | 4.617M |
| September 30, 2019 | 4.162M |
| June 30, 2019 | 4.278M |
| March 31, 2019 | 4.391M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 5.103M |
| Fortress Biotech, Inc. | 46.07M |
| Kura Oncology, Inc. | 23.16M |
| Legend Biotech Corp. | 121.80M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |